Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

PMI

Picard Medical Inc

Jan 16 • 04:00PM ET

1.64

-0.06 -3.53 %

Healthcare • Medical Devices • USA • AMEX

Index	RUT	P/E	-	EPS (ttm)	-0.51	Insider Own	64.53%	Shs Outstand	73.70M	Perf Week	-2.38%
Market Cap	120.87M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	26.14M	Perf Month	-28.70%
Enterprise Value	118.68M	PEG	-	EPS next Q	-	Inst Own	0.77%	Short Float	2.56%	Perf Quarter	-84.08%
Income	-33.80M	P/S	25.34	EPS this Y	-	Inst Trans	0.58%	Short Ratio	0.38	Perf Half Y	-
Sales	4.77M	P/B	15.17	EPS next Y	-	ROA	-245.79%	Short Interest	0.67M	Perf YTD	-6.29%
Book/sh	0.11	P/C	43.01	EPS next 5Y	-	ROE	-	52W High	13.68 -88.01%	Perf Year	-
Cash/sh	0.04	P/FCF	-	EPS past 3/5Y	-36.87% -	ROIC	-414.78%	52W Low	1.63 0.61%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	3.32% -	Gross Margin	-10.83%	Volatility	5.46% 8.23%	Perf 5Y	-
Dividend TTM	-	EV/Sales	24.88	EPS Y/Y TTM	-77.65%	Oper. Margin	-289.61%	ATR (14)	0.21	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.94	Sales Y/Y TTM	8.97%	Profit Margin	-707.92%	RSI (14)	36.82	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-101.16%	SMA20	-13.00%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.08	Sales Q/Q	34.73%	SMA50	-28.23%	Rel Volume	0.08	Prev Close	1.70
Employees	75	LT Debt/Eq	0.02	Earnings	-	SMA200	-66.53%	Avg Volume	1.76M	Price	1.64
IPO	Aug 29, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	136,342	Change	-3.53%

Jan-13-26 09:00AM	Picard / SynCardia Featured on the Cruxx of MedTech Podcast (GlobeNewswire)
Jan-12-26 08:30AM	SynCardia and Hydrix Enter into Development Collaboration to Advance the Emperor, SynCardia's Next Generation Total Artificial Heart (GlobeNewswire)
Jan-07-26 08:00AM	Picard Medical Announces Conference Participation During J.P. Morgan Healthcare Conference Week (GlobeNewswire) +10.40%
Jan-06-26 08:00AM	Picard Medical to Begin Rollout of FDA-Cleared Accessory for its SynCardia Total Artificial Heart (GlobeNewswire)
Dec-30-25 08:00AM	Picard Medical CEO Patrick NJ Schnegelsberg Elected to AZBio Board of Directors (GlobeNewswire) -6.42%
06:25AM	Loading…
Dec-26-25 06:25AM	Picard Medical enters agreement for $50m senior secured notes (Medical Device Network) -6.19%
Dec-24-25 09:36AM	Picard Medical Announces Up to $50 Million Senior Secured Debt Financing (GlobeNewswire)
Dec-18-25 08:55AM	NYSE Content Advisory: Pre-Market Update + NYSE Gets Festive with Gap in Holiday Campaign (PR Newswire) +10.31%
08:30AM	Picard Medical Marks Public Company Milestone by Ringing the NYSE Opening Bell (GlobeNewswire)
Dec-09-25 04:05PM	Picard Celebrates Patient Living a World-Record of Over Eight Years with the SynCardia Total Artificial Heart (GlobeNewswire) -8.71%
Dec-03-25 04:05PM	Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany (GlobeNewswire) +82.67%
Nov-26-25 07:00AM	Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 (GlobeNewswire)
Nov-19-25 04:05PM	SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart (GlobeNewswire) -6.69% -7.17%
Nov-14-25 07:00AM	Picard Reports Third Quarter 2025 Financial Results (GlobeNewswire) +10.66%
Nov-12-25 08:00AM	Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City (GlobeNewswire)
08:00AM	Loading…
Nov-03-25 08:00AM	Picard to Showcase its Total Artificial Heart at the Annual Meeting of the American Heart Association 2025 (GlobeNewswire) +6.18%
Oct-24-25 03:07PM	Picard Issues Statement on Intraday Stock Price (GlobeNewswire) -59.77%
Oct-08-25 10:51AM	Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product (Business Wire)
Sep-22-25 08:00AM	Picard Advances Patent Protection for Fully Implantable Artificial Heart Technology (GlobeNewswire)
Sep-15-25 08:00AM	Picard Medical Reports Second Quarter 2025 Financial Results (GlobeNewswire) +6.29%
Sep-10-25 08:00AM	Picard Announces Appointment of Two New Members to its Board of Directors (GlobeNewswire)
Sep-09-25 04:05PM	Picard Medical, Inc. Announces Exercise of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering (GlobeNewswire)
Sep-08-25 07:00AM	Picard Medical, Inc. Announces Presentation at H.C. Wainwright Global Investment Conference (GlobeNewswire) +13.85%
Sep-02-25 04:05PM	Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering (GlobeNewswire) +11.98%

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PMI

Picard Medical Inc

Upgrade your FINVIZ experience